![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 2, 1311-1316, January 12, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Biochemistry and the Institute for Molecular
Bioscience, The University of Queensland, Brisbane,
Queensland 4072, Australia
The oncogene GLI1 is involved in the
formation of basal cell carcinoma and other tumor types as a result of
the aberrant signaling of the Sonic hedgehog-Patched pathway. In this
study, we have identified alternative GLI1 transcripts that
differ in their 5' untranslated regions (UTRs) and are generated by
exon skipping. These are denoted
Post-transcriptional Regulation of the GLI1 Oncogene
by the Expression of Alternative 5' Untranslated Regions*
-UTR,
-UTR, and
-UTR
according to the number of noncoding exons possessed (three, two, and
one, respectively). The
- and
-UTR forms represent the major
Gli1 transcripts expressed in mouse tissues, whereas the
-UTR is present at relatively low levels but is markedly induced in
mouse skin treated with 12-O-tetradecanoylphorbol 13-acetate. Transcripts corresponding to the murine
and
forms were identified in human tissues, but significantly, only the
-UTR
form was present in basal cell carcinomas and in proliferating cultures of a keratinocyte cell line. Flow cytometry analysis determined that the
-UTR variant expresses a heterologous reporter gene 14-23-fold higher than the
-UTR and 5-13-fold higher than the
-UTR in a variety of cell types. Because expression of the
-UTR
variant correlates with proliferation, consistent with a role for GLI1
in growth promotion, up-regulation of GLI1 expression through skipping of 5' noncoding exons may be an important tumorigenic mechanism.
*
This work was supported by the Queensland Cancer Fund and
the University of Queensland Cancer Research Fund.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by a Wellcome Trust Senior Research Fellowship in
Medical Research (Australia). To whom correspondence should be addressed. Tel.: 61-7-3365-4629; Fax: 61-7-3365-4699; E-mail: josephr@biosci.uq.edu.au.
This article has been cited by other articles:
![]() |
T. Shimokawa, U. Tostar, M. Lauth, R. Palaniswamy, M. Kasper, R. Toftgard, and P. G. Zaphiropoulos Novel Human Glioma-associated Oncogene 1 (GLI1) Splice Variants Reveal Distinct Mechanisms in the Terminal Transduction of the Hedgehog Signal J. Biol. Chem., May 23, 2008; 283(21): 14345 - 14354. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Davies, J. I. Vandenberg, R. A. Sayeed, and A. E. O. Trezise Cardiac Expression of the Cystic Fibrosis Transmembrane Conductance Regulator Involves Novel Exon 1 Usage to Produce a Unique Amino-terminal Protein J. Biol. Chem., April 16, 2004; 279(16): 15877 - 15887. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Wang and J. A. Rothnagel 5'-Untranslated regions with multiple upstream AUG codons can support low-level translation via leaky scanning and reinitiation Nucleic Acids Res., February 27, 2004; 32(4): 1382 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shalev, P. J. Blair, S. C. Hoffmann, B. Hirshberg, B. A. Peculis, and D. M. Harlan A Proinsulin Gene Splice Variant with Increased Translation Efficiency Is Expressed in Human Pancreatic Islets Endocrinology, July 1, 2002; 143(7): 2541 - 2547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kozak Constraints on reinitiation of translation in mammals Nucleic Acids Res., December 15, 2001; 29(24): 5226 - 5232. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |